17-GYN-05-XB (VX-EC-2-02) A Phase 2, Single-Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma

Grants and Contracts Details

StatusFinished
Effective start/end date9/15/17 → 6/10/19

Funding

  • Xenetic Biosciences Incorporated: $20,216.00